Zobrazeno 1 - 10
of 293
pro vyhledávání: '"Fomekong Nanfack Y"'
Autor:
Evers A; Computational Chemistry & Biologics (CCB), Merck Healthcare KGaA, Darmstadt, Germany. Andreas.Evers@merckgroup.com., Malhotra S; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA., Bolick WG; Ginkgo Analytics GmbH, Hamburg, Germany., Najafian A; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA., Borisovska M; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA., Warszawski S; Computational Chemistry & Biologics, Merck KGaA, Yavne, Israel., Fomekong Nanfack Y; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA., Kuhn D; Computational Chemistry & Biologics (CCB), Merck Healthcare KGaA, Darmstadt, Germany., Rippmann F; Computational Chemistry & Biologics (CCB), Merck Healthcare KGaA, Darmstadt, Germany., Crespo A; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA., Sood V; Computational Chemistry & Biologics (CCB), EMD Serono, Billerica, MA, USA.
Publikováno v:
Methods in molecular biology (Clifton, N.J.) [Methods Mol Biol] 2023; Vol. 2681, pp. 383-398.
Autor:
Jin H; the healthcare business of Merck KGaA, Darmstadt, Germany., D'Urso V; the healthcare business of Merck KGaA, Darmstadt, Germany., Neuteboom B; Istituto di Ricerche Biomediche 'A. Marxer' RBM S.p.A. Colleretto Giacosa, Italy, an affiliate of Merck KGaA, Darmstadt, Germany., McKenna SD; EMD Serono, Billerica, MA, USA., Schweickhardt R; Istituto di Ricerche Biomediche 'A. Marxer' RBM S.p.A. Colleretto Giacosa, Italy, an affiliate of Merck KGaA, Darmstadt, Germany., Gross AW; EMD Serono, Billerica, MA, USA., Fomekong Nanfack Y; EMD Serono, Billerica, MA, USA., Paoletti A; Istituto di Ricerche Biomediche 'A. Marxer' RBM S.p.A. Colleretto Giacosa, Italy, an affiliate of Merck KGaA, Darmstadt, Germany., Carter C; EMD Serono, Billerica, MA, USA., Toleikis L; the healthcare business of Merck KGaA, Darmstadt, Germany., Fluck M; the healthcare business of Merck KGaA, Darmstadt, Germany., Scheuenpflug J; the healthcare business of Merck KGaA, Darmstadt, Germany., Cai T; EMD Serono, Billerica, MA, USA.
Publikováno v:
Oncoimmunology [Oncoimmunology] 2021 Aug 29; Vol. 10 (1), pp. 1958590. Date of Electronic Publication: 2021 Aug 29 (Print Publication: 2021).
Autor:
D'Orsi, Laura1 (AUTHOR) laura.dorsi@biomatematica.it, Capasso, Biagio2 (AUTHOR) biagio.capasso@marina.difesa.it, Lamacchia, Giuseppe3 (AUTHOR) giuseppe.lamacchia@reginaapostolorum.it, Pizzichini, Paolo4 (AUTHOR) pizzichinipaolo@gmail.com, Ferranti, Sergio2 (AUTHOR) sergio.ferranti@esercito.difesa.it, Liverani, Andrea3 (AUTHOR) andrea.liverani@reginaapostolorum.it, Fontana, Costantino4 (AUTHOR) costantino.fontana@esercito.difesa.it, Panunzi, Simona1 (AUTHOR) simona.panunzi@biomatematica.it, De Gaetano, Andrea1,5,6 (AUTHOR) andrea.degaetano@irib.cnr.it, Lo Presti, Elena5 (AUTHOR) elena.lopresti@cnr.it
Publikováno v:
International Journal of Molecular Sciences. Nov2024, Vol. 25 Issue 21, p11588. 19p.
Autor:
Grinshpun B; Discovery & Development Technologies, Drug Disposition & Design, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA., Thorsteinson N; Department of Scientific Services, Chemical Computing Group ULC, Montreal, Quebec, Canada., Pereira JN; Discovery & Development Technologies, Drug Disposition & Design, Merck Healthcare KGaA, Darmstadt, Germany., Rippmann F; Discovery & Development Technologies, Drug Disposition & Design, Merck Healthcare KGaA, Darmstadt, Germany., Nannemann D; Discovery & Development Technologies, Drug Disposition & Design, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA., Sood VD; Discovery & Development Technologies, Drug Disposition & Design, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA., Fomekong Nanfack Y; Discovery & Development Technologies, Drug Disposition & Design, EMD Serono Research & Development Institute, Inc, Billerica, MA, USA.
Publikováno v:
MAbs [MAbs] 2021 Jan-Dec; Vol. 13 (1), pp. 1932230.
Autor:
Yeo, Hock Chuan1 (AUTHOR), Vijay, Varsheni2 (AUTHOR), Selvarajoo, Kumar1,2,3,4 (AUTHOR) kumar_selvarajoo@bii.a-star.edu.sg
Publikováno v:
BMC Biology. 10/14/2024, Vol. 22 Issue 1, p1-21. 21p.
Autor:
Stader, Felix1 (AUTHOR) felix.stader@certara.com, Liu, Cong1 (AUTHOR), Derbalah, Abdallah1 (AUTHOR), Momiji, Hiroshi1 (AUTHOR), Pan, Xian1 (AUTHOR), Gardner, Iain1 (AUTHOR), Jamei, Masoud1 (AUTHOR), Sepp, Armin1 (AUTHOR)
Publikováno v:
Antibodies (2073-4468). Sep2024, Vol. 13 Issue 3, p70. 12p.
Autor:
Fomekong Nanfack, Y.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::8410cca43e578d90372a9139aae7d03f
https://dare.uva.nl/personal/pure/en/publications/genetic-regulatory-networks-inference--modeling-parameters-estimation--model-validation(ee64066f-5b0e-4503-a02e-2b25f83136f7).html
https://dare.uva.nl/personal/pure/en/publications/genetic-regulatory-networks-inference--modeling-parameters-estimation--model-validation(ee64066f-5b0e-4503-a02e-2b25f83136f7).html
Publikováno v:
FEBS Journal, 276(4), 886-902
Mathematical models of biological processes have various applications: to assist in understanding the functioning of a system, to simulate experiments before actually performing them, to study situations that cannot be dealt with experimentally, etc.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=narcis______::3a58db1869b752d29314dbb315a6e767
https://ir.cwi.nl/pub/13387
https://ir.cwi.nl/pub/13387
Autor:
Vigolo M; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Chambers MG; Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA., Willen L; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Chevalley D; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Maskos K; Proteros Biostructures GmbH, 82152, Planegg, Germany., Lammens A; Proteros Biostructures GmbH, 82152, Planegg, Germany., Tardivel A; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Das D; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Kowalczyk-Quintas C; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Schuepbach-Mallepell S; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Smulski CR; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Eslami M; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland., Rolink A; Department of Biomedicine, University of Basel, 4058, Basel, Switzerland., Hummler E; Department of Pharmacology and Toxicology, University of Lausanne, 1011, Lausanne, Switzerland., Samy E; EMD Serono Research & Development Institute, Billerica, MA, 01821, USA., Fomekong Nanfack Y; EMD Serono Research & Development Institute, Billerica, MA, 01821, USA., Mackay F; Department of Immunology, Monash University, Melbourne, VIC, 3004, Australia., Liao M; Department of Cell Biology, Harvard Medical School, Boston, MA, 02115, USA., Hess H; Merck KGaA, 64293, Darmstadt, Germany., Jiang X; EMD Serono Research & Development Institute, Billerica, MA, 01821, USA., Schneider P; Department of Biochemistry, University of Lausanne, 1066, Epalinges, Switzerland. pascal.schneider@unil.ch.
Publikováno v:
Nature communications [Nat Commun] 2018 Mar 23; Vol. 9 (1), pp. 1199. Date of Electronic Publication: 2018 Mar 23.
Autor:
McFadden, Johnjoe1 (AUTHOR) j.mcfadden@surrey.ac.uk
Publikováno v:
Annals of the New York Academy of Sciences. Dec2023, Vol. 1530 Issue 1, p8-17. 10p.